|
The stocks making the biggest moves in premarket trading include Lyft, Las Vegas Sands, Wendy's, and more.
|
|
The Dow is set to drop at Wednesday's open, with futures erasing earlier gains as bond yield moved higher.
|
|
 Twilio Inc. said Wednesday it is planning to issue $1 billion of unsecured, senior notes in the cloud communications platform's latest capital raise. The San Francisco-based company raised $1.54 billion in an equity offering in February. Proceeds of the bond deal will be used for general corporate purposes, including potential acquisitions, strategic investments, refinancing or repayment of debt, capex, working capital and share buybacks. JP Morgan, Morgan Stanley and BofA Securities are lead underwriters on the deal. Twilio shares were up 0.8% premarket and have gained 275% in the last 12 months, while the S&P 500 has gained 29%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
 John Buckingham of the Prudent Speculator newsletter selects stocks he would buy today, based on expected earnings growth and low valuations.
|
|
Boston Scientific Corp. announced Wednesday an agreement to buy the global surgical business of Lumenis LTD for $1.07 billion in cash from Baring Private Equity Asia. The medical technology company said Lumentis's surgical business includes laser systems, fibers and accessories used for urology and otolaryngology procedures, and is expected to have 2021 sales of about $200 million. "The MOSES laser technology, paired with our LithoVue(TM) Single-Use Digital Flexible Ureteroscope and comprehensive kidney stone management portfolio, will enable execution of our strategy for our stone franchise," said Meghan Scanlon, president of urology and pelvic health at Boston Scientific. The stock, which was still inactive in premarket trading, has rallied 14.6% over the past three months, while the S&P 500 has gained 5.6%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 114.8 million on Wednesday, according to data aggregated by Johns Hopkins University, while the death toll rose above 2.55 million. The U.S. has the highest case tally in the world at 28.7 million and the highest death toll at 516,616. The U.S. added 57,789 new cases on Tuesday, according to a New York Times tracker, and at least 1,306 people died. The U.S. has averaged 65,468 cases a day in the past week, down 19% from two weeks ago. There was good news from President Joe Biden who said the U.S. expects to take delivery of enough coronavirus vaccine for all adults by the end of May - two months earlier than anticipated - and he pushed states to get at least one shot into the arms of teachers by the end of March to hasten school reopenings.
Brazil has the second highest death toll at 257,361 and is third by cases at 10.6 million. India is second worldwide in cases with 11.1 million, and fourth in deaths at 157,346. Mexico has the third highest death toll at 187,187 and 13th highest case tally at 2.1 million. The U.K. has 4.2 million cases and 123,530 deaths, the highest in Europe and fifth highest in the world.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
|
Brown-Forman Corp. said Wednesday it had net income of $219 million, or 45 cents a share, in its fiscal third quarter to Jan. 31, down from $231 million, or 48 cents a share, in the year-earlier period. Sales rose to $911 million from $899 million a year ago. The FactSet consensus was for EPS of 43 cents and sales of $902 million. The company said the Jack Daniels family of brands saw sales fall 2% in the year to date, while premium bourbons sales rose 18%. The tequila portfolio's sales rose 2%. "Underlying net sales in Travel Retail continued to be significantly impacted by the continuation of COVID-19 related travel bans and restrictions," the company said in a statement. Brown-Forman is not offering guidance, given the uncertainty created by the pandemic. Shares were not active premarket, but have gained 13% in the last 12 months, while the S&P 500 has gained 29%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
|
RELATED ARTICLES | | | | |
|
 These 25 undervalued stocks are good prospects based on rapid earnings growth
|
|
Dow Jones Futures Rise After Stock Market Rally Falls To Key Levels; Vaccine Play Soars Late Investor's Business DailyWall Street ends lower, tech stocks retreat ReutersStock futures rise in early morning trading after Tuesday's losses CNBCStocks edge down as investors hit pause, watch bond yields ReutersNasdaq 100 Soars Back Above 50-SMA FX Empire
|
|
 Nokia losing its spot in European stock-market index Stoxx 50
|
|
